| Nome |
# |
|
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells, file e27ce426-dd5b-2581-e053-d805fe0acbaa
|
447
|
|
NO-Donor Dihydroartemisinin Derivatives as Multitarget Agents for the Treatment of Cerebral Malaria, file e27ce427-b4cc-2581-e053-d805fe0acbaa
|
370
|
|
4-Hydroxy-1,2,5-oxadiazol-3-yl Moiety as Bioisoster of the Carboxy Function. Synthesis, Ionization Constants, and Molecular Pharmacological Characterization at Ionotropic Glutamate Receptors of Compounds Related to Glutamate and Its Homologues, file e27ce426-cbfc-2581-e053-d805fe0acbaa
|
355
|
|
Multitarget Drugs: Focus on the NO-donor hybrid drugs, file e27ce426-b4e8-2581-e053-d805fe0acbaa
|
331
|
|
Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs), file e27ce426-be80-2581-e053-d805fe0acbaa
|
306
|
|
Nitrooxymethyl-Substituted Analogues of Rofecoxib: Synthesis and Pharmacological Characterization, file e27ce426-cbf4-2581-e053-d805fe0acbaa
|
261
|
|
Synthesis and preliminary biological profile of new NO-donor tolbutamide analogues., file e27ce426-d5c3-2581-e053-d805fe0acbaa
|
260
|
|
Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugs, file e27ce426-d83a-2581-e053-d805fe0acbaa
|
253
|
|
Amodiaquine analogues containing NO-donor substructures: Synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malaria, file e27ce426-bdc3-2581-e053-d805fe0acbaa
|
250
|
|
New nitric oxide or hydrogen sulfide releasing aspirins, file e27ce426-d99c-2581-e053-d805fe0acbaa
|
245
|
|
NO-Donor Phenols: A New Class of Products Endowed with Antioxidant and Vasodilator Properties, file e27ce426-aadd-2581-e053-d805fe0acbaa
|
228
|
|
Carnosine analogues containing NO-donor substructures: Synthesis, physico-chemical characterization and preliminary pharmacological profile, file e27ce426-ead8-2581-e053-d805fe0acbaa
|
227
|
|
Nitrooxymethyl Substituted Analogues of Celecoxib: Synthesis and Pharmacological Characterization, file e27ce426-b8e0-2581-e053-d805fe0acbaa
|
224
|
|
Searching for new NO-donor aspirin-like molecules: furoxanylacyl derivatives of salicylic acid and related furazans, file e27ce426-dd5a-2581-e053-d805fe0acbaa
|
202
|
|
New potential uroselective NO-donor a1-antagonists, file e27ce426-aaf8-2581-e053-d805fe0acbaa
|
197
|
|
Water-Soluble Nitric-Oxide-Releasing Acetylsalicylic Acid
(ASA) Prodrugs, file e27ce426-f7b4-2581-e053-d805fe0acbaa
|
197
|
|
Phenylsulfonylfuroxans as Modulators of Multidrug-Resistance-Associated Protein-1 and P-Glycoprotein, file e27ce426-c64d-2581-e053-d805fe0acbaa
|
196
|
|
A molecular hybrid producing simultaneously singlet oxygen and nitric oxide by single photon excitation with green light, file e27ce42d-b04b-2581-e053-d805fe0acbaa
|
195
|
|
Multitarget Drugs: Synthesis and Preliminary Pharmacological Characterization of Zileuton Analogues Endowed with Dual 5-LO Inhibitor and NO-Dependent Activities, file e27ce426-bf24-2581-e053-d805fe0acbaa
|
190
|
|
Novel Antioxidant Agents Deriving From Molecular Combination of Vitamin C and NO-donor moieties, file e27ce426-aaa3-2581-e053-d805fe0acbaa
|
179
|
|
NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties, file e27ce426-ae93-2581-e053-d805fe0acbaa
|
172
|
|
Doxorubicin-antioxidant multitarget drugs, file e27ce426-f93b-2581-e053-d805fe0acbaa
|
144
|
|
Synthesis and biological evaluation of the first example of NO-donor
histone deacetylase inhibitor, file e27ce426-f223-2581-e053-d805fe0acbaa
|
134
|
|
Edaravone derivatives containing NO-donor functions, file e27ce426-bc77-2581-e053-d805fe0acbaa
|
133
|
|
1,2,5-Oxadiazole analogues of leflunomide and related compounds, file e27ce426-ca8a-2581-e053-d805fe0acbaa
|
124
|
|
NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties, file e27ce426-ae92-2581-e053-d805fe0acbaa
|
111
|
|
Combination of PDT and NOPDT with a tailored BODIPY derivative, file e27ce42e-df95-2581-e053-d805fe0acbaa
|
102
|
|
Synthesis, physico-chemical characterization, andbiological activities of new carnosine derivatives stablein human serum as potential neuroprotective agents, file e27ce426-c650-2581-e053-d805fe0acbaa
|
100
|
|
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance, file e27ce428-be10-2581-e053-d805fe0acbaa
|
92
|
|
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins, file e27ce426-b275-2581-e053-d805fe0acbaa
|
89
|
|
A multi-photoresponsive molecular-hybrid for dual-modal photoinactivation of cancer cells, file e27ce427-03dc-2581-e053-d805fe0acbaa
|
84
|
|
New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoni, file e27ce427-03db-2581-e053-d805fe0acbaa
|
77
|
|
Searching for Balanced Hybrid NO-Donor 1,4-Dihydropyridines with Basic Properties, file e27ce426-aaf2-2581-e053-d805fe0acbaa
|
72
|
|
New nitric oxide or hydrogen sulfide releasing aspirins, file e27ce426-d99d-2581-e053-d805fe0acbaa
|
72
|
|
Searching for new NO-donor Aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid, file e27ce426-bbb7-2581-e053-d805fe0acbaa
|
71
|
|
Doxorubicin-antioxidant multitarget drugs, file e27ce426-f93a-2581-e053-d805fe0acbaa
|
70
|
|
NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease, file e27ce427-2d2f-2581-e053-d805fe0acbaa
|
67
|
|
Effects of Nitric Oxide Donor Antioxidants Containing the Phenol Vitamin E Substructure and a Furoxan Moiety on Ischemia/Riperfusion Injury, file e27ce426-bc73-2581-e053-d805fe0acbaa
|
66
|
|
Multitarget Drugs: Synthesis and Preliminary Pharmacological Characterization of Zileuton Analogues Endowed with Dual 5-LO Inhibitor and NO-Dependent Activities, file e27ce426-bf25-2581-e053-d805fe0acbaa
|
63
|
|
Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants, file e27ce426-b11b-2581-e053-d805fe0acbaa
|
60
|
|
Nitrooxymethyl Substituted Analogues of Celecoxib: Synthesis and Pharmacological Characterization, file e27ce426-b8e1-2581-e053-d805fe0acbaa
|
60
|
|
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance, file e27ce428-bf82-2581-e053-d805fe0acbaa
|
60
|
|
Phenylsulfonylfuroxans as Modulators of Multidrug-Resistance-Associated Protein-1 and P-Glycoprotein, file e27ce426-c64c-2581-e053-d805fe0acbaa
|
59
|
|
A Nonmetal-Containing Nitric Oxide Donor Activated with Single-Photon Green Light, file e27ce42c-1578-2581-e053-d805fe0acbaa
|
59
|
|
A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity, file e27ce426-b440-2581-e053-d805fe0acbaa
|
57
|
|
Quinone based nitric oxide donating compounds, file e27ce427-a390-2581-e053-d805fe0acbaa
|
57
|
|
NO-Donor Melatonin Derivatives: Synthesis And In Vitro Pharmacological Characterization, file e27ce426-bbd1-2581-e053-d805fe0acbaa
|
56
|
|
Tuning the Hydrophobicity of a Mitochondria-Targeted NO Photodonor, file e27ce42c-bcef-2581-e053-d805fe0acbaa
|
54
|
|
Designing Multitarget Anti-inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors., file e27ce427-b2ad-2581-e053-d805fe0acbaa
|
51
|
|
Synthesis of Some Novel Organic Nitrates and Comparative in Vitro Study of Their Vasodilator Profile, file e27ce426-baef-2581-e053-d805fe0acbaa
|
50
|
|
Edaravone derivatives containing NO-donor functions, file e27ce426-bc79-2581-e053-d805fe0acbaa
|
50
|
|
Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity, file e27ce426-c49d-2581-e053-d805fe0acbaa
|
50
|
|
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma, file e27ce432-dd86-2581-e053-d805fe0acbaa
|
40
|
|
Light-Tunable Generation of Singlet Oxygen and Nitric Oxide with a Bichromophoric Molecular Hybrid: a Bimodal Approach to Killing Cancer Cells, file e27ce429-141a-2581-e053-d805fe0acbaa
|
38
|
|
New inhibitors of dihydroorotate dehydrogenase (DHODH) based on the 4-hydroxy-1,2,5-oxadiazol-3-yl (hydroxyfurazanyl) scaffold, file e27ce426-edc2-2581-e053-d805fe0acbaa
|
37
|
|
Multitarget Drugs: No-Donor Doxorubicins, file e27ce427-664a-2581-e053-d805fe0acbaa
|
35
|
|
New furoxan derivatives for the treatment of ocular hypertension, file e27ce42b-615d-2581-e053-d805fe0acbaa
|
35
|
|
Inhibition of Human Placenta Glutathione Transferase P1-1 by the Antibiotic Calvatic Acid and its Diazocyanide Analogue: Evidence for Multiple Catalytic Intermediates, file e27ce426-9fe5-2581-e053-d805fe0acbaa
|
34
|
|
Novel R-roscovitine NO-donor hybrid compounds as potential
pro-resolution of inflammation agents, file e27ce426-df67-2581-e053-d805fe0acbaa
|
34
|
|
Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth, file e27ce426-b444-2581-e053-d805fe0acbaa
|
33
|
|
New furoxan derivatives for the treatment of ocular hypertension, file e27ce42b-15a7-2581-e053-d805fe0acbaa
|
31
|
|
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance, file e27ce42b-3a6a-2581-e053-d805fe0acbaa
|
31
|
|
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts, file e27ce42e-af48-2581-e053-d805fe0acbaa
|
30
|
|
Structure-Activity Relationship Studies on Tetrahydroisoquinoline Derivatives: [4′-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-ylmethyl)biphenyl-4-ol] (MC70) Conjugated through Flexible Alkyl Chains with Furazan Moieties Gives Rise to Potent and Selective Ligands of P-glycoprotein, file e27ce42a-1188-2581-e053-d805fe0acbaa
|
28
|
|
Nitrooxymethyl-Substituted Analogues of Rofecoxib: Synthesis and Pharmacological Characterization, file e27ce426-cbf5-2581-e053-d805fe0acbaa
|
27
|
|
Synthesis of Some Novel Organic Nitrates and Comparative in Vitro Study of Their Vasodilator Profile, file e27ce426-baf0-2581-e053-d805fe0acbaa
|
26
|
|
A Molecular Hybrid for Mitochondria-Targeted NO Photodelivery, file e27ce42c-8ff2-2581-e053-d805fe0acbaa
|
23
|
|
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance, file e27ce42b-59af-2581-e053-d805fe0acbaa
|
22
|
|
Fluorescent Nitric Oxide Photodonors Based on BODIPY and Rhodamine Antennae, file e27ce432-ebba-2581-e053-d805fe0acbaa
|
22
|
|
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors, file e27ce433-469a-2581-e053-d805fe0acbaa
|
22
|
|
Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity, file e27ce426-c49c-2581-e053-d805fe0acbaa
|
21
|
|
Multitarget Drugs: No-Donor Doxorubicins, file e27ce427-664b-2581-e053-d805fe0acbaa
|
21
|
|
Novel water soluble furoxan derivatives having antitumor activity, file e27ce427-0441-2581-e053-d805fe0acbaa
|
20
|
|
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors, file e27ce42c-ef0f-2581-e053-d805fe0acbaa
|
20
|
|
A generator of peroxynitrite activatable with red light, file e27ce432-66d7-2581-e053-d805fe0acbaa
|
20
|
|
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins, file e27ce426-b276-2581-e053-d805fe0acbaa
|
16
|
|
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells, file e27ce426-dd5c-2581-e053-d805fe0acbaa
|
16
|
|
NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease, file e27ce427-2d32-2581-e053-d805fe0acbaa
|
15
|
|
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma, file e27ce42e-1c89-2581-e053-d805fe0acbaa
|
15
|
|
Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugs, file e27ce426-d83b-2581-e053-d805fe0acbaa
|
13
|
|
Fluorescent Nitric Oxide Photodonors Based on BODIPY and Rhodamine Antennae, file e27ce42e-af49-2581-e053-d805fe0acbaa
|
12
|
|
6-Cyclohexylmethoxy-5-(cyano-NNO-azoxy)pyrimidine-4-amine: A new scaffold endowed with potent CDK2 inhibitory activity, file e27ce429-8f34-2581-e053-d805fe0acbaa
|
8
|
|
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors, file e27ce42c-a984-2581-e053-d805fe0acbaa
|
7
|
|
New inhibitors of dihydroorotate dehydrogenase (DHODH) based on the 4-hydroxy-1,2,5-oxadiazol-3-yl (hydroxyfurazanyl) scaffold, file e27ce426-edc1-2581-e053-d805fe0acbaa
|
6
|
|
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance, file e27ce42b-2369-2581-e053-d805fe0acbaa
|
6
|
|
A Nonmetal-Containing Nitric Oxide Donor Activated with Single-Photon Green Light, file e27ce42b-e9f5-2581-e053-d805fe0acbaa
|
6
|
|
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma, file e27ce42e-0506-2581-e053-d805fe0acbaa
|
5
|
|
Fluorescent Nitric Oxide Photodonors Based on BODIPY and Rhodamine Antennae, file e27ce42e-a491-2581-e053-d805fe0acbaa
|
5
|
|
Water-Soluble Nitric-Oxide-Releasing Acetylsalicylic Acid
(ASA) Prodrugs, file e27ce426-f7b5-2581-e053-d805fe0acbaa
|
4
|
|
Searching for new NO-donor aspirin-like molecules: furoxanylacyl derivatives of salicylic acid and related furazans, file e27ce427-cd40-2581-e053-d805fe0acbaa
|
4
|
|
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins, file e27ce426-b5e2-2581-e053-d805fe0acbaa
|
3
|
|
Physicochemical profile and in vitro permeation behavior of a new class of non-steroidal anti-inflammatory drug candidates, file e27ce426-c4db-2581-e053-d805fe0acbaa
|
3
|
|
Carnosine analogues containing NO-donor substructures: Synthesis, physico-chemical characterization and preliminary pharmacological profile, file e27ce426-ead9-2581-e053-d805fe0acbaa
|
3
|
|
6-Cyclohexylmethoxy-5-(cyano-NNO-azoxy)pyrimidine-4-amine: A new scaffold endowed with potent CDK2 inhibitory activity, file e27ce426-f28e-2581-e053-d805fe0acbaa
|
3
|
|
NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease, file e27ce427-3667-2581-e053-d805fe0acbaa
|
3
|
|
A multi-photoresponsive molecular-hybrid for dual-modal photoinactivation of cancer cells, file e27ce428-589d-2581-e053-d805fe0acbaa
|
3
|
|
New furoxan derivatives for the treatment of ocular hypertension, file e27ce42b-615c-2581-e053-d805fe0acbaa
|
3
|
|
Tuning the Hydrophobicity of a Mitochondria-Targeted NO Photodonor, file e27ce42c-fa2c-2581-e053-d805fe0acbaa
|
3
|
|
NO-Donor Dihydroartemisinin Derivatives as Multitarget Agents for the Treatment of Cerebral Malaria, file e27ce433-5823-2581-e053-d805fe0acbaa
|
3
|
|
Identification of 2,3-diaminophenazine and of o-benzoquinone dioxime as the major in vitro metabolites of benzofuroxan, file e27ce426-a049-2581-e053-d805fe0acbaa
|
2
|
| Totale |
8.496 |